UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 202

Sortiert nach

Higher adenoma detection rates with endocuff-assisted colonoscopy - a randomized controlled multicenter trial

PloS one, 2014-12, Vol.9 (12), p.e114267-e114267

2014

Link zum Volltext

Verfügbarkeit prüfen

Age-Related Risk Profile and Chemotherapy Dose Response in Acute Myeloid Leukemia: A Study by the German Acute Myeloid Leukemia Cooperative Group

Journal of clinical oncology, 2009-01, Vol.27 (1), p.61-69

2009

Link zum Volltext

Verfügbarkeit prüfen

Acute Myeloid Leukemia (AML): Different Treatment Strategies Versus a Common Standard Arm—Combined Prospective Analysis by the German AML Intergroup

Journal of clinical oncology, 2012-10, Vol.30 (29), p.3604-3610

2012

Link zum Volltext

Verfügbarkeit prüfen

Late valvular and other cardiac diseases after different doses of mediastinal radiotherapy for hodgkin disease in children and adolescents: Report from the longitudinal GPOH follow-up project of the German-Austrian DAL-HD studies

Pediatric blood & cancer, 2010-12, Vol.55 (6), p.1145-1152

2010

Link zum Volltext

Verfügbarkeit prüfen

Allogeneic Transplantation Versus Chemotherapy as Postremission Therapy for Acute Myeloid Leukemia: A Prospective Matched Pairs Analysis

Journal of clinical oncology, 2014-02, Vol.32 (4), p.288-296

2014

Link zum Volltext

Verfügbarkeit prüfen

ERG Expression Is an Independent Prognostic Factor and Allows Refined Risk Stratification in Cytogenetically Normal Acute Myeloid Leukemia: A Comprehensive Analysis of ERG, MN1, and BAALC Transcript Levels Using Oligonucleotide Microarrays

Journal of clinical oncology, 2009-10, Vol.27 (30), p.5031-5038

2009

Link zum Volltext

Verfügbarkeit prüfen

Risk factors for recurrent venous thromboembolism in the European collaborative paediatric database on cerebral venous thrombosis: a multicentre cohort study

Lancet neurology, 2007-07, Vol.6 (7), p.595-603

2007

Link zum Volltext

Verfügbarkeit prüfen

Prospective assessment of risk factors for recurrent stroke during childhood-a 5-year follow-up study

The Lancet (British edition), 2002-11, Vol.360 (9345), p.1540-1545

2002

Link zum Volltext

Verfügbarkeit prüfen

Treatment Results in Localized Primary Gastric Lymphoma: Data of Patients Registered Within the German Multicenter Study (GIT NHL 02/96)

Journal of clinical oncology, 2005-10, Vol.23 (28), p.7050-7059

2005

Link zum Volltext

Verfügbarkeit prüfen

The NPM1 mutation type has no impact on survival in cytogenetically normal AML

PloS one, 2014-10, Vol.9 (10), p.e109759

2014

Link zum Volltext

Verfügbarkeit prüfen

Chromosomal imbalances, loss of heterozygosity, and immunohistochemical expression of TP53, RB1, and PTEN in intraductal cancer, intraepithelial neoplasia, and invasive adenocarcinoma of the prostate

Genes chromosomes & cancer, 2008-07, Vol.47 (7), p.565-572

2008

Link zum Volltext

Verfügbarkeit prüfen

Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long-term outcome in acute myeloid leukemia: data from the German AML Cooperative Group (AMLCG) 1992 Trial

Blood, 2003-01, Vol.101 (1), p.64-70

2003

Link zum Volltext

Verfügbarkeit prüfen

Allogeneic transplantation as post-remission therapy for cytogenetically high-risk acute myeloid leukemia: landmark analysis from a single prospective multicenter trial

Haematologica (Roma), 2011-07, Vol.96 (7), p.972-979

2011

Link zum Volltext

Verfügbarkeit prüfen

Prevalence, associations, and trends of biliary-tract candidiasis: a prospective observational study

Gastrointestinal endoscopy, 2009-09, Vol.70 (3), p.480-487

2009

Link zum Volltext

Verfügbarkeit prüfen

6-Thioguanine, Cytarabine, and Daunorubicin (TAD) and High-Dose Cytarabine and Mitoxantrone (HAM) for Induction, TAD for Consolidation, and Either Prolonged Maintenance by Reduced Monthly TAD or TAD-HAM-TAD and One Course of Intensive Consolidation by Sequential HAM in Adult Patients at All Ages With De Novo Acute Myeloid Leukemia (AML): A Randomized Trial of the German AML Cooperative Group

Journal of clinical oncology, 2003-12, Vol.21 (24), p.4496-4504

2003

Link zum Volltext

Verfügbarkeit prüfen

Thickness of masticatory mucosa

Journal of clinical periodontology, 2000-06, Vol.27 (6), p.431-436

2000

Link zum Volltext

Verfügbarkeit prüfen

Management of Acute Myeloid Leukemia in Elderly Patients

Journal of clinical oncology, 1999-11, Vol.17 (11), p.3569-3576

1999

Link zum Volltext

Verfügbarkeit prüfen

Morphologic Dysplasia in De Novo Acute Myeloid Leukemia (AML) Is Related to Unfavorable Cytogenetics but Has No Independent Prognostic Relevance Under the Conditions of Intensive Induction Therapy: Results of a Multiparameter Analysis From the German AML Cooperative Group Studies

Journal of clinical oncology, 2003-01, Vol.21 (2), p.256-265

2003

Link zum Volltext

Verfügbarkeit prüfen

Subgingival Plaque Removal at Interdental Sites Using a Low‐Abrasive Air Polishing Powder

Journal of periodontology (1970), 2003-03, Vol.74 (3), p.307-311

2003

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 202

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(177)
Mit Volltextzugriff
(186)

Publikationsform

Artikel
(179)
Buchkapitel
(20)
Bücher
(3)

Sprache

Englisch
(181)
Japanisch
(26)
Deutsch
(21)

Erscheinungsjahr

n.n

Thema

Humans
(104)
Science & Technology
(103)
Life Sciences & Biomedicine
(101)
Male
(77)
Female
(74)
Middle Aged
(74)
Biological And Medical Sciences
(71)
Medical Sciences
(71)
Adult
(63)
Aged
(53)
Adolescent
(37)
Oncology
(36)
Hematologic And Hematopoietic Diseases
(32)
Hematology
(31)
Prognosis
(30)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(27)
Aged, 80 And Over
(26)
Prospective Studies
(26)
Treatment Outcome
(25)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(23)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Sorafenib in Combination With Intensive Chemotherapy in Elderly Patients With Acute Myeloid Leukemia: Results From a Randomized, Placebo-Controlled Trial

Higher adenoma detection rates with endocuff-assisted colonoscopy - a randomized controlled multicenter trial

An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia

Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomes

Age-Related Risk Profile and Chemotherapy Dose Response in Acute Myeloid Leukemia: A Study by the German Acute Myeloid Leukemia Cooperative Group

Acute Myeloid Leukemia (AML): Different Treatment Strategies Versus a Common Standard Arm—Combined Prospective Analysis by the German AML Intergroup

Late valvular and other cardiac diseases after different doses of mediastinal radiotherapy for hodgkin disease in children and adolescents: Report from the longitudinal GPOH follow-up project of the German-Austrian DAL-HD studies

Combined molecular and clinical prognostic index for relapse and survival in cytogenetically normal acute myeloid leukemia

Effect of preoperative chemoradiation in addition to preoperative chemotherapy: a randomised trial in stage III non-small-cell lung cancer

Allogeneic Transplantation Versus Chemotherapy as Postremission Therapy for Acute Myeloid Leukemia: A Prospective Matched Pairs Analysis

ERG Expression Is an Independent Prognostic Factor and Allows Refined Risk Stratification in Cytogenetically Normal Acute Myeloid Leukemia: A Comprehensive Analysis of ERG, MN1, and BAALC Transcript Levels Using Oligonucleotide Microarrays

Risk factors for recurrent venous thromboembolism in the European collaborative paediatric database on cerebral venous thrombosis: a multicentre cohort study

Prospective assessment of risk factors for recurrent stroke during childhood-a 5-year follow-up study

Treatment Results in Localized Primary Gastric Lymphoma: Data of Patients Registered Within the German Multicenter Study (GIT NHL 02/96)

The NPM1 mutation type has no impact on survival in cytogenetically normal AML

Double Induction Containing Either Two Courses or One Course of High-Dose Cytarabine Plus Mitoxantrone and Postremission Therapy by Either Autologous Stem-Cell Transplantation or by Prolonged Maintenance for Acute Myeloid Leukemia

Chromosomal imbalances, loss of heterozygosity, and immunohistochemical expression of TP53, RB1, and PTEN in intraductal cancer, intraepithelial neoplasia, and invasive adenocarcinoma of the prostate

Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long-term outcome in acute myeloid leukemia: data from the German AML Cooperative Group (AMLCG) 1992 Trial

Allogeneic transplantation as post-remission therapy for cytogenetically high-risk acute myeloid leukemia: landmark analysis from a single prospective multicenter trial

Prevalence, associations, and trends of biliary-tract candidiasis: a prospective observational study

Thickness of masticatory mucosa

Management of Acute Myeloid Leukemia in Elderly Patients

Morphologic Dysplasia in De Novo Acute Myeloid Leukemia (AML) Is Related to Unfavorable Cytogenetics but Has No Independent Prognostic Relevance Under the Conditions of Intensive Induction Therapy: Results of a Multiparameter Analysis From the German AML Cooperative Group Studies

Subgingival Plaque Removal at Interdental Sites Using a Low‐Abrasive Air Polishing Powder

Suchergebnisse filtern